
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1115 | 1060 | 1085 | 1367 | 1722 | 1678 |
Fund Return | 11.48% | 5.96% | 8.51% | 10.97% | 11.48% | 5.31% |
Place in category | 364 | 335 | 522 | 342 | 429 | 416 |
% in Category | 14 | 15 | 23 | 16 | 27 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AllianzIncome Growth P H2EUR | 55.53B | 5.33 | 7.39 | 5.71 | ||
AllianzIncome Growth A H2EUR | 55.53B | 4.96 | 6.81 | 5.08 | ||
AllianzIncome Growth IT H2EUR | 55.53B | 5.29 | 7.52 | 5.80 | ||
AllianzIncome Growth CT H2EUR | 55.53B | 4.51 | 5.96 | 4.26 | ||
AllianzIncome Growth RT H2EUR | 55.53B | 5.27 | 7.34 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eleva Euro Slct Class A1 EUR Acc | 7.68B | 8.74 | 11.66 | 6.90 | ||
Eleva Euro Slct Class A2 EUR Acc | 7.68B | 8.42 | 11.19 | 6.39 | ||
Eleva Euro Slct Class R EUR Acc | 7.68B | 9.12 | 12.23 | 7.41 | ||
Eleva Euro Slct Class I EUR Acc | 7.68B | 9.13 | 12.27 | 7.51 | ||
European Growth Fund E Acc EUR | 24.67M | 6.36 | 11.98 | 4.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Allianz Eurp Eq pwrd by Artfcl IntlgcWT€ | LU2397364675 | 6.55 | - | - | |
ASML Holding | NL0010273215 | 2.72 | 636.70 | -0.96% | |
SAP | DE0007164600 | 2.57 | 237.000 | -1.11% | |
Novartis | CH0012005267 | 2.54 | 99.49 | +0.93% | |
Roche Holding Participation | CH0012032048 | 2.13 | 256.00 | +2.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review